The role of podocyte injury in the pathogenesis of focal segmental glomerulosclerosis

Renal Failure

Volumn 22, Issue 6, 2000, Pages 663-684

  Schwartz, M M ^a  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY INJURY; NONHUMAN; PATHOGENESIS; PODOCYTE; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; SCAR FORMATION;

ANIMALS; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; KIDNEY GLOMERULUS; KIDNEY TRANSPLANTATION; RECURRENCE;

EID: 0033736590     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100101955     Document Type: Conference Paper

References (53)

1. Studies on familial nephrosis: II. Glomerular changes observed with the electron microscope
2. Anatomy
3. Glomerular epithelial cells
4. Pathogenesis and significance of nonprimary focal and segmental glomerulosclerosis
5. Pathology of the nephrotic syndrome: A report for the International Study of Kidney Disease in Children
6. The prognosis of focal segmental glomerular sclerosis of adulthood
7. The nephrotic syndrome: Minimal change disease, focal segmental glomerulosclerosis and miscellaneous causes
8. Primary focal segmental glomerulosclerosis: Pathology, histologic variants, and pathogenesis
9. The many masks of focal segmental glomerulosclerosis
10. Primary focal segmental glomerulosclerosis in adults: Prognostic value of histologic variants
11. The glomerular tip lesion: A previously undescribed type of segmental glomerular abnormality
12. Further studies on the glomerular tip lesion: Early and late stages and life table analysis
13. Focal segmental glomerular sclerosis: The cellular lesion
14. Nephrotic syndrome, progressive irreversible renal failure and glomerular 'collapse': A new clinicopathologic entity?
15. Collapsing glomerulopathy: A clinically and pathologically distinct variant of focal segmental glomerulosclerosis
16. Idiopathic collapsing focal segmental glomerulosclerosis: A clinicopathologic study
17. Collapsing glomerulopathy: Expanding interest in a shrinking tuft
18. Glomerulosclerosis in the remnant kidney rat is modulated by dietary alphatocopherol
19. Apoptosis in glomerular sclerosis
20. Focal glomreulosclerosis in the remnant kidney modelan inflammatory disease mediated by cytokines
21. Urinary transforming growth factor-beta (TGF-beta) excretion and renal production of TGF-beta in rats with subtoal renal ablation: Effect of enalapril and nifedipine
22. Cyclosporine induces glomerulosclerosis: Three-dimensional definition of the lesions in a rat model of renal transplant
23. Supplementation with L-2-oxothiazolidine-4-carboxylic acid, a cysteine precursor, does not protect against lipid peroxidation in puromycin aminonucleoside-induced nephropathy
24. Short- or long-term effects of a low-protein diet on fibronectin and transforming growth factor-beta synthesis in adriamycin-induced nephropathy
25. TGF-beta behavior in the progressive process in the focal glomerulosclerosis rat model: The role of latent TGF-beta-binding protein
26. Heparin-binding epidermal growth factor-like growth factor is expressed in the adhesive lesions of experimental focal glomerular sclerosis
27. Focal segmental glomerulosclerosis in primates infected with a simian immunodeficiency virus
28. Glomerular overproduction of oxygen radicals in Mpv17 gene-inactivated mice causes podocyte foot process flattening and proteinuria: A model of steroid-resistant nephrosis sensitive to radical scavenger therapy
29. Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension
30. Development of vascular pole-associated glomerulosclerosis in the Fawn-hooded rat
31. Early influx of glomerular macrophages precedes glomerulosclerosis in the obese Zucker rat model
32. Candesartan prevents the progression of glomerulosclerosis in genetic hypertensive rats
33. The development of focal segmental glomerulosclerosis in masugi nephritis is based on progressive podocyte damage
34. Renal transplant pathology
35. Recurrent focal segmental glomerulosclerosis. A patholgical study of the early lesion
36. Recurrent nephrotic syndrome in renal allografts
37. Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis
38. Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome
39. Plasmapheresis reduces proteinuria and serum capacity to injure glomeruli in patients with recurrent focal glomerulosclerosis
40. Pathogenesis of polycation-induced alteration (fusion) of glomrular epithelium
41. Polycation-induced dislocation of slit diaphragms and formation of cell junctions in rat kidney glomeruli. The effects of low temperature, divalent cations, colchicine and cytochalasion B
42. Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes
43. Alteration of glomerular permeability to macromolecules induced by cross-linking of beta-1 integrin receptors
44. Plasmapheresis in the treatment of steroid-resistant focal segmental glomerulosclerosis in native kidneys
45. The cellular lesion of focal segmental glomerulosclerosis: Therapeutic response and prognosis
46. Focal glomerular sclerosis in nephrotic patients: An electron microscopic study of glomerular podocytes
47. Progressive renal failure-inability of podocytes to replicate and the consequences for development of glomerulosclerosis
48. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy
49. Origin and phenotypic features of hyperplastic epithelial cells in collapsing glomerulopathy
50. The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy
51. WT1 and PAX2 podocyte expression in Denys-Drash syndrome and isolated diffuse mesangial sclerosis
52. Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities
53. Pax-2 controls multiple steps of urogenital development